Related Experiment Video
Updated: May 5, 2026

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
2.4K
Robot-assisted laparoscopic partial nephrectomy: Early single Canadian institution experience
Guillaume Ploussard1, Richard Haddad, Evan Kovac
1Department of Urology, Jewish General Hospital, McGill University, Montreal, QC.
Summary
Robot-assisted partial nephrectomy (RALPN) is a safe and feasible option for complex kidney tumors, demonstrating good outcomes and low morbidity. Surgeon experience and tumor complexity influence warm ischemia time, with improved results over time.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Oncology
Background:
- Robot-assisted partial nephrectomy (RALPN) is gaining traction, yet open surgery remains the benchmark for nephron-sparing procedures.
- This study details the initial surgical outcomes of RALPN at a single institution.
Purpose of the Study:
- To evaluate the initial surgical outcomes of robot-assisted partial nephrectomy (RALPN).
- To assess the safety, feasibility, and early outcomes of RALPN for various renal masses.
Main Methods:
- Retrospective analysis of 65 consecutive RALPN cases performed by two surgeons between January 2011 and February 2013.
- Data collected included preoperative characteristics (R.E.N.A.L. nephrometry score), perioperative parameters, and postoperative outcomes (renal function, complications).
- Mean follow-up was 12 months.
Main Results:
- The mean patient age was 60.2 years, with a mean tumor size of 3.9 cm. Tumors were moderately (51%) and highly (18.5%) complex based on R.E.N.A.L. score.
- Median warm ischemia time (WIT) was 21 minutes, influenced by R.E.N.A.L. score, tumor size, complications, and surgeon experience.
- Overall complication rate was 24.6% (decreasing to 12% after 20 cases), with a trifecta rate of 64.3% for complex tumors after the initial learning curve. Mean eGFR change was -6.7 mL/min without severe renal failure.
Conclusions:
- RALPN is a safe and feasible nephron-sparing procedure for renal masses, including complex ones, with low morbidity.
- Warm ischemia time is linked to tumor complexity and surgeon experience, which improves over time.
- Further follow-up is necessary to confirm the long-term oncologic outcomes.

